Ming Guo Selected Research

Hypoxia (Hypoxemia)

3/2021	Targeting Hypoxic Tumors with Hybrid Nanobullets for Oxygen-Independent Synergistic Photothermal and Thermodynamic Therapy.
7/2004	Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming Guo Research Topics

Disease

57	Neoplasms (Cancer) 03/2024 - 07/2002
22	Infections 05/2024 - 11/2012
11	Inflammation (Inflammations) 08/2023 - 10/2016
10	Carcinoma (Carcinomatosis) 10/2021 - 02/2007
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 02/2012
8	COVID-19 05/2024 - 01/2020
7	Uterine Cervical Dysplasia 12/2023 - 12/2004
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2016
7	Tuberculosis (Tuberculoses) 09/2019 - 06/2002
7	Parkinson Disease (Parkinson's Disease) 12/2016 - 06/2006
6	Myocardial Infarction 01/2024 - 03/2015
6	Anhedonia 01/2023 - 04/2011
6	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2008
5	Carcinogenesis 02/2024 - 07/2008
5	Coronary Disease (Coronary Heart Disease) 01/2024 - 01/2016
5	Insulin Resistance 08/2023 - 12/2009
5	Type 2 Diabetes Mellitus (MODY) 08/2023 - 12/2009
4	Fibrosis (Cirrhosis) 01/2024 - 03/2015
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2023 - 10/2009
4	Heart Failure 11/2023 - 01/2021
4	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2022 - 04/2014
4	Neoplasm Metastasis (Metastasis) 03/2021 - 02/2011
4	Muscular Diseases (Myopathy) 05/2020 - 01/2017
4	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 10/2009
4	Atypical Squamous Cells of the Cervix 02/2015 - 08/2008
3	Disease Resistance 01/2024 - 01/2021
3	Cataract (Cataracts) 01/2024 - 01/2022
3	Autoimmune Diseases (Autoimmune Disease) 07/2023 - 10/2016
3	Acute Coronary Syndrome 01/2023 - 05/2021
3	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 04/2019
3	Squamous Cell Carcinoma of Head and Neck 01/2021 - 08/2002
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2019
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 07/2002
3	Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia 05/2020 - 01/2017
3	Frontotemporal Dementia (Semantic Dementia) 05/2020 - 01/2017
3	Atherosclerosis 04/2020 - 01/2016
3	Virus Diseases (Viral Diseases) 03/2020 - 01/2013
3	Reperfusion Injury 01/2020 - 01/2016
2	Pneumonia (Pneumonitis) 05/2024 - 02/2021
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2024 - 01/2020
2	Nasopharyngeal Carcinoma 01/2024 - 12/2007
2	Cognitive Dysfunction 08/2023 - 07/2012
2	Wounds and Injuries (Trauma) 05/2023 - 01/2022
2	AIDS-Related Complex (ARC) 01/2023 - 01/2023
2	Thyroid Neoplasms (Thyroid Cancer) 01/2023 - 02/2013
2	Multiple Sclerosis 01/2022 - 10/2016

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2003
11	VaccinesIBA 05/2024 - 12/2014
10	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2011
9	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 02/2007
8	Phosphotransferases (Kinase)IBA 01/2024 - 06/2006
8	CytokinesIBA 01/2022 - 03/2014
6	SaponinsIBA 01/2024 - 01/2018
6	AntigensIBA 01/2018 - 03/2007
5	MicroRNAs (MicroRNA)IBA 01/2024 - 11/2008
5	Messenger RNA (mRNA)IBA 08/2022 - 01/2009
5	Niacinamide (Nicotinamide)FDA LinkGeneric 12/2013 - 12/2009
4	Blood Glucose (Blood Sugar)IBA 01/2024 - 01/2012
4	Glucose (Dextrose)FDA LinkGeneric 06/2023 - 05/2010
4	Peptides (Polypeptides)IBA 05/2023 - 10/2003
4	Therapeutic UsesIBA 01/2023 - 07/2011
4	RNA (Ribonucleic Acid)IBA 01/2023 - 03/2010
4	Circular RNAIBA 01/2023 - 01/2022
3	Monoclonal AntibodiesIBA 05/2024 - 09/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 03/2015
3	Amyloid (Amyloid Fibrils)IBA 01/2024 - 10/2003
3	EnzymesIBA 04/2023 - 04/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 02/2012
3	Interleukin-2 (IL2)IBA 12/2022 - 07/2002
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 02/2012
3	LipidsIBA 01/2022 - 01/2014
3	Anaplastic Lymphoma KinaseIBA 03/2021 - 10/2020
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 07/2002
3	Valosin Containing ProteinIBA 05/2020 - 01/2017
3	Formaldehyde (Formol)FDA Link 01/2019 - 02/2007
3	ParaffinIBA 01/2019 - 02/2007
3	SmokeIBA 01/2018 - 07/2011
3	Estrogen ReceptorsIBA 01/2013 - 01/2009
2	Cadherins (E-Cadherin)IBA 03/2024 - 01/2016
2	Type 4 Fibroblast Growth Factor ReceptorIBA 02/2024 - 03/2022
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 02/2024 - 03/2022
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2024 - 03/2010
2	Hematoxylin (Haematoxylon)IBA 01/2024 - 03/2010
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2024 - 11/2023
2	Interleukin-6 (Interleukin 6)IBA 01/2024 - 07/2017
2	C-Reactive ProteinIBA 01/2024 - 11/2012
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2024 - 10/2018
2	Nucleic AcidsIBA 01/2023 - 09/2021
2	cupric sulfide (CuS)IBA 01/2023 - 12/2022
2	Long Noncoding RNAIBA 01/2023 - 01/2022
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	Insulin (Novolin)FDA Link 01/2022 - 01/2012

Therapy/Procedure

22	Therapeutics 02/2024 - 08/2002
7	Drug Therapy (Chemotherapy) 01/2023 - 07/2002
6	Immunotherapy 01/2023 - 01/2020
6	Percutaneous Coronary Intervention 01/2023 - 01/2016
6	Radiotherapy 01/2021 - 12/2007
4	Oral Administration 11/2022 - 04/2010
3	Lasers (Laser) 03/2021 - 08/2020
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2023 - 01/2023